Food for Thought … Systems Toxicology

Summary The need for a more mechanistic understanding of the ways in which chemicals modulate biological pathways is urgent if we are to identify and better assess safety issues relating to a wide range of substances developed by the pharmaceutical, chemical, agri-bio, and cosmetic industries. Omics technologies provide a valuable opportunity to refine existing methods and provide information for so-called integrated testing strategies via the creation of signatures of toxicity. By mapping these signatures to underlying pathways of toxicity, some of which have been identified by toxicologists over the last few decades, and bringing them together with pathway information determined from biochemistry and molecular biology, a "systems toxicology" approach will enable virtual experiments to be conducted that can improve the prediction of hazard and the assessment of compound toxicity.

[1]  Donald G Robertson,et al.  Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  C Winder,et al.  Toxicity Assessment of Industrial Chemicals and Airborne Contaminants: Transition from In Vivo to In Vitro Test Methods: A Review , 2005, Inhalation toxicology.

[3]  F. Gage,et al.  Identification of small molecules from human embryonic stem cells using metabolomics. , 2007, Stem cells and development.

[4]  D. Rank,et al.  Application of genomics to toxicology research. , 2002, Environmental health perspectives.

[5]  Sebastian Hoffmann,et al.  Integrated Testing Strategy (ITS) - Opportunities to better use existing data and guide future testing in toxicology. , 2010, ALTEX.

[6]  Elaine Holmes,et al.  Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. , 2006, Journal of proteome research.

[7]  Thomas Hartung,et al.  Food for thought...on alternative methods for chemical safety testing. , 2010, ALTEX.

[8]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[9]  Daniel Raftery,et al.  Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes , 2010, PloS one.

[10]  M. Rand,et al.  Drosophotoxicology: the growing potential for Drosophila in neurotoxicology. , 2010, Neurotoxicology and teratology.

[11]  Thomas Hartung,et al.  Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[12]  Erwin van Vliet,et al.  Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. , 2011, ALTEX.

[13]  B. Hammock,et al.  Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.

[14]  S. Theocharis,et al.  Toxicogenomics: a pivotal piece in the puzzle of toxicological research , 2007, Journal of applied toxicology : JAT.

[15]  T. Williams,et al.  Individual variation in endocrine systems: moving beyond the ‘tyranny of the Golden Mean’ , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  David S Wishart,et al.  Human Metabolome Database: completing the 'human parts list'. , 2007, Pharmacogenomics.

[17]  Tijana Milenkoviæ,et al.  Uncovering Biological Network Function via Graphlet Degree Signatures , 2008, Cancer informatics.

[18]  H. Selye The Stress of Life , 1958 .

[19]  F. Schreiber,et al.  Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks , 2008, Gene regulation and systems biology.

[20]  P. Landrigan,et al.  Developmental neurotoxicity of industrial chemicals , 2006, The Lancet.

[21]  Gerald T Ankley,et al.  Toxicogenomics in regulatory ecotoxicology. , 2006, Environmental science & technology.

[22]  Thomas Hartung,et al.  Toward a New Toxicology — Evolution or Revolution? , 2008, Alternatives to laboratory animals : ATLA.

[23]  Erwin van Vliet,et al.  Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. , 2011 .

[24]  J. T. Macgregor,et al.  The future of regulatory toxicology: impact of the biotechnology revolution. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  T. Hartung,et al.  A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. , 2008, Neurotoxicology.

[26]  M. Balls,et al.  Mechanistic approaches and the development of alternative toxicity test methods. , 1998, Environmental health perspectives.

[27]  Lee Weng,et al.  Toxicogenomic analysis methods for predictive toxicology. , 2006, Journal of pharmacological and toxicological methods.

[28]  Thomas Hartung,et al.  Food for Thought ... on mapping the human toxome. , 2011, ALTEX.

[29]  S. Kennedy The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[30]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[31]  J. Pennings,et al.  Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  P. Grandjean,et al.  Developmental neurotoxicity of industrial chemicals – Authors' reply , 2007, The Lancet.

[33]  Thomas Hartung,et al.  A Toxicology for the 21st Century—Mapping the Road Ahead , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  F. A. Rodrigues,et al.  Resilience of protein-protein interaction networks as determined by their large-scale topological features. , 2011, Molecular bioSystems.

[35]  Barbara A Wetmore,et al.  Toxicoproteomics: proteomics applied to toxicology and pathology. , 2004, Toxicologic pathology.

[36]  Andrew Worth,et al.  Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.

[37]  V. Thongboonkerd Urinary proteomics: towards biomarker discovery, diagnostics and prognostics. , 2008, Molecular bioSystems.

[38]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[39]  James T. Mac Grego Toxicology and Genetic Toxicology in the New Era of "Toxicogenomics": Impact of "-omics" Technologies , 2003 .

[40]  Gordon Vansant,et al.  Gene expression profiling of rat livers reveals indicators of potential adverse effects. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  Leming Shi,et al.  Using RNA sample titrations to assess microarray platform performance and normalization techniques , 2006, Nature Biotechnology.

[42]  Maqc Consortium The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[43]  A. Wagner DOES EVOLUTIONARY PLASTICITY EVOLVE? , 1996, Evolution; international journal of organic evolution.

[44]  Deborah I. Bunin,et al.  Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  Jerry L. Campbell,et al.  Formaldehyde: integrating dosimetry, cytotoxicity, and genomics to understand dose-dependent transitions for an endogenous compound. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  D J Dix,et al.  Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics. , 2011, Toxicology and applied pharmacology.

[47]  F. Campos,et al.  Methylmercury disrupts the balance between phosphorylated and non-phosphorylated cofilin in primary cultures of mice cerebellar granule cells. A proteomic study. , 2010, Toxicology and applied pharmacology.

[48]  J. Pennings,et al.  Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity. , 2010, Reproductive toxicology.

[49]  Ben van Ommen,et al.  Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology , 2005, Expert review of proteomics.

[50]  Thomas Hartung,et al.  From alternative methods to a new toxicology. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[51]  P. West,et al.  Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. , 2010, Toxicology and applied pharmacology.

[52]  Ola Spjuth,et al.  Computational toxicology using the OpenTox application programming interface and Bioclipse , 2011, BMC Research Notes.

[53]  C. Mummery,et al.  Proteomics and human embryonic stem cells. , 2008, Stem cell research.

[54]  Ruedi Aebersold,et al.  7th HUPO World Congress of Proteomics: Launching the Second Phase of the HUPO Plasma Proteome Project (PPP‐2) 16–20 August 2008, Amsterdam, The Netherlands , 2009, Proteomics.

[55]  Robert J Kavlock,et al.  Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  Imran Shah,et al.  Using pathway modules as targets for assay development in xenobiotic screening. , 2012, Molecular bioSystems.

[57]  Thomas Hartung,et al.  Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)). , 2009, ALTEX.

[58]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[59]  Michael D. Waters,et al.  Toxicogenomics and systems toxicology: aims and prospects , 2004, Nature Reviews Genetics.

[60]  Mark Bennett,et al.  A novel method for the genome-wide high resolution analysis of DNA damage , 2010, Nucleic Acids Res..

[61]  T Hartung,et al.  Three Rs potential in the development and quality control of pharmaceuticals. , 2001, ALTEX.

[62]  Glen A. Evans,et al.  Designer science and the “omic” revolution , 2000, Nature Biotechnology.

[63]  Darrell R Boverhof,et al.  Toxicogenomics in risk assessment: applications and needs. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[64]  Hilda Witters,et al.  The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. , 2010, Reproductive toxicology.

[65]  Hanlee P. Ji,et al.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.

[66]  H. Keun,et al.  Metabonomic modeling of drug toxicity. , 2006, Pharmacology & therapeutics.

[67]  Shibing Deng,et al.  Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  J. Bailar,et al.  Toxicity testing in the 21st century—a vision and a strategy , 2012 .

[69]  Petra S Kern,et al.  Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case. , 2011, ALTEX.